ENDV · Endonovo Therapeutics, Inc. · Holdings
$0.00
At close · Nov 9
Return incl. dividend (before tax)
Going-concern doubt
— flagged Dec 29, 2023
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt as to its ability to continue as going concern within one year from issuance date of these unaudited consolidated financial statements.”View the 10-Q filed Dec 29, 2023
Market Cap
$31,875
Shares
318.75M
Volume · Nov 9
500K
Avg daily vol (3M)
753.37K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.
Use institutional holdings through the 13F API or MCP →
See every holder of ENDV: 13F, 13D and 13G, insiders and funds →
Some SEC filings for this period have not finished importing. Holder totals and changes may be incomplete; these filings remain queued for recovery.
No Holdings Data
No institutional holdings data is available for this listed security yet.